Question explored with the scientific record
Conversation so far
- 1 Non drug based blood pressure reductions that work
- 2 Do bodies have a set point for blood pressure that resists drug effects
- 3 Why do some people develop tolerance or stop responding to drugs?
- 4 What secondary causes should be screened for if meds don’t work?
Answered on this page ↓
What secondary causes should be screened for if meds don’t work?
The short version: when drugs fail, the two causes worth screening first are sleep apnea and primary aldosteronism, a hormone problem where the adrenal glands overproduce aldosterone.
In a study of 3,003 people with high blood pressure, 1,186 had a secondary cause; sleep apnea was the most common at 742, and primary aldosteronism next at 175 [4]. In resistant hypertension specifically, sleep apnea shows up in 60 to 70 percent of cases and aldosteronism in 7 to 20 percent [6]. Aldosteronism is more common than older teaching assumed, at 6.3 percent of a referral-center population, and it is not always tied to severe pressure [1].
| Secondary cause | Share of resistant hypertension |
|---|---|
| Sleep apnea | 60-70% [6] |
| Primary aldosteronism | 7-20% [6] |
| Renal artery stenosis | 2-24% [6] |
Aldosteronism is worth finding because it is treatable and the treatment changes outcomes. A case report describes a patient whose pressure normalized after surgery [3]. In a 2021 review, surgery for one-sided disease beat drugs on heart rhythm and kidney outcomes, though the comparison was retrospective, not a randomized trial [2].
The screening tests are simple: an aldosterone-to-renin ratio for aldosteronism, and a sleep study for apnea [6]. The ratio can be run on most blood pressure drugs, but aldosterone-blocking drugs like spironolactone should be stopped first [6]. A seated ratio works as well as a lying-down one, with a cutoff of 19 pg/UI giving 85.7 percent sensitivity and 89.7 percent specificity [7].
This retrieval does not cover pheochromocytoma, Cushing's syndrome, thyroid disease, or kidney artery narrowing in enough depth to rank them, though a review lists them as recognized causes [5]. The evidence on how much treating sleep apnea lowers pressure is modest: CPAP cut pressure by 3 to 5 points, or 7 to 10 with good adherence [6].
My call: screen for aldosteronism and sleep apnea first when drugs fail, because both are common and both are treatable. Confidence: moderate.
Sources used 7
-
Primary aldosteronism in a referral hypertension center
This study evaluates the prevalence and characteristics of primary aldosteronism (PA) in hypertensive patients, revealing that PA is more common than previously thought and not necessarily associated with severe hypertension.
DOI: 10.1016/s0895-7061(01)01336-x -
Therapeutic Outcomes with Surgical and Medical Management of Primary Aldosteronism
This 2021 review summarizes the diagnosis and management of primary aldosteronism (PA), highlighting that adrenalectomy yields superior cardiovascular and renal outcomes for unilateral PA compared with mineralocorticoid receptor antagonists (MRAs), while complete pharmacologic b…
DOI: 10.1007/s11886-021-01516-0 -
Not All Hypertension Is a Lifelong Disease
This case study illustrates the diagnosis and successful treatment of primary aldosteronism in a patient with resistant hypertension and hypokalemia, emphasizing the importance of screening for secondary causes of hypertension.
DOI: 10.1001/jamainternmed.2020.0361 -
Detection of Secondary Causes and Coexisting Diseases in Hypertensive Patients: OSA and PA Are the Common Causes Associated with Hypertension
This study investigates the prevalence of secondary causes and coexisting diseases in hypertensive patients, finding that obstructive sleep apnea (OSA) and primary aldosteronism (PA) are the most common contributors.
DOI: 10.1155/2017/8295010 -
Resistant Hypertension Workup and Approach to Treatment
A comprehensive review of resistant hypertension, detailing how to distinguish true resistance from pseudoresistance, identify secondary causes, optimize pharmacologic regimens (notably diuretics and mineralocorticoid blockade), and discuss emerging interventional therapies such…
DOI: 10.4061/2011/598694 -
Resistant Hypertension
This 2014/2018-era review synthesizes current knowledge on resistant hypertension, detailing its definitions, prevalence, secondary etiologies (eg, obstructive sleep apnea and primary aldosteronism), diagnostic approaches, and evidence-based management strategies ranging from li…
DOI: 10.1001/jama.2014.5180 -
Effect of postural changes on aldosterone to plasma renin ratio in patients with suspected secondary hypertension
This prospective, single-centre study shows that seated aldosterone-to-renin ratio (ARR) strongly correlates with supine and upright ARR in patients with suspected secondary hypertension and, using a lower seated ARR cut-off (19 pg/UI), provides improved sensitivity while mainta…
DOI: 10.1016/j.ancard.2015.04.017